Cognizant

US · CTSH #764 by market cap Listed 1970

57.07 -0.15 -0.26%

Live - 5344 symbols - heartbeat 293s ago · 2026-10-08 04:01

Pre-market 57.06 -0.02%

After-hours 57.25 +0.32%

Overnight 57.10 +0.05%

Market cap: 25.71B
P/E (TTM): 12.25
P/B: 1.78
EPS: 4.56
Div yield: 2.24%
52W pos: 42%

Reader sentiment Are you bullish or bearish on CTSH?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 5.53, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +6.95% YoY

Margins

Gross margin: 33.72%
Operating margin: 15.76%
Net margin: 10.56%

Key ratios & quality

Enterprise value: 24.52B
Altman Z-Score: 5.53

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	16.13B	16.78B	16.65B	18.51B	19.43B	19.35B	19.74B	21.11B
Gross profit	6.29B	6.15B	5.98B	6.90B	6.98B	6.69B	6.78B	7.12B
Selling & admin expenses	3.01B	2.97B	3.10B	3.50B	3.44B	3.25B	3.22B	3.24B
Research & development	--	--	--	--	--	--	--	--
Operating profit	2.82B	2.67B	2.33B	2.83B	2.97B	2.92B	3.03B	3.33B
Pretax profit	2.80B	2.54B	2.10B	2.83B	3.02B	2.79B	2.94B	3.48B
Tax	698.00M	643.00M	704.00M	693.00M	730.00M	668.00M	713.00M	1.26B
Net profit	2.10B	1.84B	1.39B	2.14B	2.29B	2.13B	2.24B	2.23B
Basic EPS	4	3	3	4	4	4	5	5
Diluted EPS	3.60	3.29	2.57	4.05	4.41	4.21	4.51	4.56

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	5.12B	5.25B	5.42B	5.33B	5.41B	5.48B
Gross profit	1.72B	1.77B	1.83B	1.80B	1.78B	1.83B
Selling & admin expenses	791.00M	810.00M	833.00M	806.00M	791.00M	728.00M
Research & development	--	--	--	--	--	--
Operating profit	791.00M	817.00M	866.00M	853.00M	843.00M	958.00M
Pretax profit	872.00M	842.00M	887.00M	878.00M	867.00M	875.00M
Tax	213.00M	197.00M	613.00M	235.00M	208.00M	231.00M
Net profit	663.00M	645.00M	274.00M	648.00M	662.00M	636.00M
Basic EPS	1	1	1	1	1	1
Diluted EPS	1.34	1.31	0.56	1.34	1.39	1.36

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	8.61B	7.61B	6.85B	7.34B	7.27B	7.51B	7.50B	7.82B
Cash & ST investments	4.51B	3.42B	2.72B	2.72B	2.50B	2.64B	2.24B	1.91B
Inventory	--	--	--	--	--	--	--	--
Total assets	15.85B	16.20B	16.92B	17.85B	17.85B	18.48B	19.97B	20.69B
Total current liabilities	2.71B	2.98B	3.54B	3.53B	3.35B	3.33B	3.59B	3.66B
Short-term debt	9.00M	240.00M	249.00M	233.00M	182.00M	186.00M	185.00M	186.00M
Long-term debt	736.00M	700.00M	663.00M	626.00M	638.00M	606.00M	875.00M	543.00M
Total liabilities	4,422,000,000.00	5,182,000,000.00	6,087,000,000.00	5,861,000,000.00	5,543,000,000.00	5,256,000,000.00	5,558,000,000.00	5,677,000,000.00
Total equity	11.42B	11.02B	10.84B	11.99B	12.31B	13.23B	14.41B	15.02B
Retained earnings	11.49B	11.02B	10.69B	11.92B	12.59B	13.30B	14.69B	15.16B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	7.55B	7.61B	8.09B	7.82B	7.84B	7.56B
Cash & ST investments	1.99B	1.81B	2.35B	1.91B	1.52B	1.05B
Inventory	--	--	--	--	--	--
Total assets	19.97B	20.16B	20.13B	20.69B	20.50B	20.83B
Total current liabilities	3.41B	3.16B	3.43B	3.66B	3.52B	3.46B
Short-term debt	188.00M	188.00M	187.00M	186.00M	173.00M	178.00M
Long-term debt	567.00M	559.00M	551.00M	543.00M	535.00M	1.53B
Total liabilities	5,068,000,000.00	4,876,000,000.00	5,237,000,000.00	5,677,000,000.00	5,432,000,000.00	6,363,000,000.00
Total equity	14.90B	15.29B	14.90B	15.02B	15.07B	14.46B
Retained earnings	15.04B	15.23B	14.94B	15.16B	15.27B	14.65B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	2.59B	2.50B	3.30B	2.50B	2.57B	2.33B	2.12B	2.88B
Depreciation & amortization	498.00M	526.00M	559.00M	574.00M	569.00M	555.00M	542.00M	550.00M
Free cash flow	2.22B	2.11B	2.90B	2.22B	2.24B	2.01B	1.83B	2.60B
Dividends paid	-468.00M	-453.00M	-480.00M	-509.00M	-564.00M	-591.00M	-600.00M	-610.00M
Stock buybacks / issuance	-1.26B	-2.25B	-1.62B	-771.00M	-1.42B	-1.06B	-605.00M	-1.38B
Ending cash balance	1.16B	2.65B	2.68B	1.79B	2.29B	2.72B	2.23B	2.63B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	400.00M	398.00M	1.23B	858.00M	274.00M	558.00M
Depreciation & amortization	136.00M	139.00M	135.00M	140.00M	141.00M	143.00M
Free cash flow	323.00M	331.00M	1.16B	781.00M	198.00M	459.00M
Dividends paid	-155.00M	-153.00M	-151.00M	-151.00M	-159.00M	-157.00M
Stock buybacks / issuance	-209.00M	-368.00M	-463.00M	-338.00M	-444.00M	-1.16B
Ending cash balance	1.98B	1.80B	2.34B	2.63B	1.50B	1.04B

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	19.02	16.41	12.74	18.72	18.85	16.65	16.21	15.16
ROA %	13.50	11.47	8.40	12.29	12.83	11.70	11.65	10.97
ROIC %	16.77	13.91	10.50	16.18	16.45	14.52	14.40	13.64
5-year avg ROE %	17.69	16.82	15.55	16.19	17.15	16.67	16.63	17.12
EBIT margin %	17.51	15.31	12.73	15.32	15.62	14.61	15.16	16.66
FCF / sales %	13.74	12.55	17.42	11.97	11.51	10.40	9.26	12.29
Current ratio	3.18	2.55	1.94	2.08	2.17	2.25	2.09	2.14
Quick ratio	2.84	2.24	1.64	1.78	1.88	1.95	1.76	1.74
Debt / assets	4.70	10.40	10.39	9.20	8.59	7.11	7.41	5.57
LT debt / equity	6.44	13.11	13.93	11.75	10.98	8.54	8.99	6.43
Interest coverage	104.59	98.81	88.33	315.11	159.74	68.98	55.41	95.03
Revenue CAGR (3Y) %	9.10	7.56	3.98	4.70	5.00	5.14	2.17	2.80
Net income CAGR (3Y) %	8.96	5.85	-2.55	0.57	7.53	15.16	1.58	-0.88
FCF CAGR (3Y) %	4.99	16.14	10.97	0.02	2.00	-11.47	-6.23	5.09

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	16.61	16.69	14.50	15.16	14.88	14.92
ROA %	12.28	12.57	10.56	10.97	11.02	10.83
ROIC %	14.97	15.14	12.92	13.64	13.57	13.23
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	15.64	15.89	16.25	16.66	16.38	16.37
FCF / sales %	10.62	11.14	12.71	12.29	11.54	12.00
Current ratio	2.22	2.41	2.36	2.14	2.23	2.18
Quick ratio	1.83	1.97	1.96	1.74	1.74	1.68
Debt / assets	5.90	5.84	5.81	5.57	5.33	10.06
LT debt / equity	6.65	6.47	6.60	6.43	6.10	13.25
Interest coverage	57.15	60.30	70.60	95.03	109.56	98.42
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Financial Services (FS) is the largest reported line at 31.62% of revenue, across 4 reported segments.
No single line clears half of revenue; Health Sciences (HS) is next at 28.68%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Financial Services (FS)31.62%

Health Sciences (HS)28.68%

Products and Resources (P&R)24.12%

Communications, Media and Technology (CMT)15.58%

Quote time 2026-10-08 04:01:15 · For reference only, not investment advice and not tailored to your situation.